Basic Information
ID: ALA4385966
Type: Functional
Description: Antitumor activity against human BT20 cells xenografted in Balb/c nu/nu mouse assessed as tumor growth inhibition at 100 mg/kg, ip administered daily for 14 days measured daily during compound dosing in presence of doxorubicin
Organism: Homo sapiens
Cell type: BT-20
Activity Charts
Bioactivity
Activity Types for Assay ALA4385966
TGI
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 712.68 | 9.01 | 9.01 |